Phase III Study of DCVAC Added to Standard Chemotherapy for Men With Metastatic Castration Resistant Prostate Cancer (VIABLE)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT02111577 |
|
Recruitment Status :
Completed
First Posted : April 11, 2014
Last Update Posted : March 26, 2020
|
Sponsor:
Sotio a.s.
Information provided by (Responsible Party):
Sotio a.s.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | December 19, 2019 |
| Actual Study Completion Date : | January 28, 2020 |